| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q | ||
8-K | Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates | ||
SCHEDULE 13G | RA CAPITAL MANAGEMENT, L.P. (Filed by) | ||
SCHEDULE 13D | Avoro Capital Advisors LLC (Filed by) | ||
SCHEDULE 13D | ELI LILLY & Co (Filed by) | ||
4 | Andreessen Marc L (Reporting) | ||
4 | GORDON CARL L (Reporting) | ||
4 | ORBIMED ADVISORS LLC (Reporting) | ||
SCHEDULE 13D | ORBIMED ADVISORS LLC (Filed by) | ||
4 | Doudna Jennifer A (Reporting) | ||
4 | Avoro Capital Advisors LLC (Reporting) | ||
4 | Staahl Brett (Reporting) |
